Homozygous Familial Hypercholesterolemia: Addressing Extreme LDL-C
Addressing extreme lipoprotein cholesterol (LDL-C) in patients with homozygous familial hypercholesterolemia (HoFH) early can help improve patient outcomes and avoid atherosclerotic cardiovascular disease, heart attack, or stroke in even the…
Read MoreHDL Cholesterol: Too Much of a Good Thing?
Can High Good Cholesterol be a Bad Thing? It is considered a well-established fact that high-density lipoprotein cholesterol (HDL-C) is a robust, inverse predictor of the risk of experiencing an…
Read MoreFamilial Hypercholesterolemia, and Elevated Triglycerides: Lipid Management in Clinical Practice
Lipid Management in Clinical Practice Familial Hypercholesterolemia (FH), the genetic condition that causes high LDL cholesterol levels, may lead to early heart attacks or heart disease if undiagnosed or untreated.…
Read MoreHomozygous Familial Hypercholesterolemia (HoFH): Patient Perspectives
Join Dr. Baum and Allison Jamison as they explore Homozygous Familial Hypercholesterolemia (HoFH) and HOFH patient perspectives. Dr. Baum shares about the etiology, prevalence, signs, symptoms, and the value of…
Read MoreLipoprotein(a) and ASCVD Risk
Dr. Marlys Koschinsky describes Lipoprotein(a) and the increased risk for atherosclerotic cardiovascular disease (ASCVD). Join Dr. Koschinsky as she discusses measurement practices, the genetic link to Lipoprotein(a), and future treatment…
Read MoreThe Role of Non-Statin Therapies in Optimal Cholesterol Management
Join Dr. Lundberg for this online course on non-statin therapies in optimal cholesterol management. This 1-hour course explores residual atherosclerotic cardiovascular disease risks and solutions for closing the treatment gap.…
Read MoreImproving Adherence to Cholesterol-lowering Therapies
Join Lynne Braun, PhD, CNP, FPCNA, FAHA, FAANP, FNLA, FAAN as she explores adherence to cholesterol-lowering therapies through patient-centered care. Dr. Braun will discuss cultural concerns along with health disparities…
Read MoreTransitioning from Acute to Chronic Lipid Management
Join Dr. Saseen as he reviews chronic lipid management techniques. Dr. Saseen discusses patient and family education techniques and possible social determinants of health barriers. The course then examines medications…
Read MoreNon-Statin Therapies for Lipid Management
Susan Halli-Demeter, RN, DNP, CLS reviews the benefits of non-statin, LDL-C-lowering therapies for patients with very high-risk atherosclerotic cardiovascular disease (ASCVD) and severe hypercholesterolemia.
Read More2021 Pharmacology Sessions
Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. This annual pharmacology CE…
Read More